InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Gustaf Albèrt. Director active across 1 company, notably IRLAB Therapeutics AB. Aggregated, 1 disclosures have been logged. Activity tracked since 3 July 2026. The latest transaction was filed on 3 July 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration